PRKN and glioma: Reduced cyclin D1 levels, selective downregulation of Akt Ser473 phosphorylation, and VEGF receptor levels in parkin‐expressing glioma cells promote G (1) phase cell cycle arrest and slow down the proliferation rate of glioma cells.18